US regulatory panel backs Pfizer’s low-dose Covid-19 vaccine for children

A healthcare worker prepares a dose of the Pfizer Covid-19 vaccine (Juan Karita/AP)

The US moved a step closer to expanding Covid-19 vaccinations for millions more children as government advisers endorsed the Pfizer vaccine for kids aged between five and 11.

A Food and Drug Administration (FDA) advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing Covid-19 in that age group outweigh any potential risks.